HeartGenetics
Private Company
Total funding raised: $3M
Overview
HeartGenetics is a Lisbon-based, ISO-certified digital health and diagnostics company that translates genetic data into actionable health reports through its proprietary HEARTDECODE software system. Its business is built on three pillars: Preventive Genetics (nutrition, fitness, wellness), Cardiovascular Genetics (thrombophilia risk), and Pharmacogenomics (personalized drug response). The company serves both consumers and healthcare specialists, positioning itself at the intersection of genetic testing, software analytics, and personalized medicine to drive value-based healthcare.
Technology Platform
Proprietary HEARTDECODE software system for intelligent genetic data analysis and reporting, integrated with an ISO-certified genetic testing laboratory.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
HeartGenetics competes with large direct-to-consumer genetic firms (e.g., 23andMe) in wellness, and with specialized clinical diagnostic labs and larger pharmacogenomic companies (e.g., OneOme, Thermo Fisher's PGx offerings) in its medical segments. Its differentiation lies in its integrated lab-software platform and specific cardiovascular expertise.